CNS Specific Antisense Oligonucleotides Market, Global Outlook and Forecast 2024-2031

Report ID: 1134268 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CNS Specific Antisense Oligonucleotides Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CNS Specific Antisense Oligonucleotides Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CNS Specific Antisense Oligonucleotides Overall Market Size
    2.1 Global CNS Specific Antisense Oligonucleotides Market Size: 2021 VS 2028
    2.2 Global CNS Specific Antisense Oligonucleotides Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CNS Specific Antisense Oligonucleotides Players in Global Market
    3.2 Top Global CNS Specific Antisense Oligonucleotides Companies Ranked by Revenue
    3.3 Global CNS Specific Antisense Oligonucleotides Revenue by Companies
    3.4 Top 3 and Top 5 CNS Specific Antisense Oligonucleotides Companies in Global Market, by Revenue in 2021
    3.5 Global Companies CNS Specific Antisense Oligonucleotides Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CNS Specific Antisense Oligonucleotides Players in Global Market
        3.6.1 List of Global Tier 1 CNS Specific Antisense Oligonucleotides Companies
        3.6.2 List of Global Tier 2 and Tier 3 CNS Specific Antisense Oligonucleotides Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global CNS Specific Antisense Oligonucleotides Market Size Markets, 2021 & 2028
        4.1.2 Polyneuropathy Treatment
        4.1.3 Spinal Muscular Atrophy (SMA) Treatment
        4.1.4 Huntington’s Disease Treatment
    4.2 By Type - Global CNS Specific Antisense Oligonucleotides Revenue & Forecasts
        4.2.1 By Type - Global CNS Specific Antisense Oligonucleotides Revenue, 2017-2022
        4.2.2 By Type - Global CNS Specific Antisense Oligonucleotides Revenue, 2023-2028
        4.2.3 By Type - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CNS Specific Antisense Oligonucleotides Market Size, 2021 & 2028
        5.1.2 Hospital Pharmacies
        5.1.3 Retail Pharmacies
        5.1.4 Online Pharmacies
    5.2 By Application - Global CNS Specific Antisense Oligonucleotides Revenue & Forecasts
        5.2.1 By Application - Global CNS Specific Antisense Oligonucleotides Revenue, 2017-2022
        5.2.2 By Application - Global CNS Specific Antisense Oligonucleotides Revenue, 2023-2028
        5.2.3 By Application - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global CNS Specific Antisense Oligonucleotides Market Size, 2021 & 2028
    6.2 By Region - Global CNS Specific Antisense Oligonucleotides Revenue & Forecasts
        6.2.1 By Region - Global CNS Specific Antisense Oligonucleotides Revenue, 2017-2022
        6.2.2 By Region - Global CNS Specific Antisense Oligonucleotides Revenue, 2023-2028
        6.2.3 By Region - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America CNS Specific Antisense Oligonucleotides Revenue, 2017-2028
        6.3.2 US CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.3.3 Canada CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.3.4 Mexico CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe CNS Specific Antisense Oligonucleotides Revenue, 2017-2028
        6.4.2 Germany CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.4.3 France CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.4.4 U.K. CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.4.5 Italy CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.4.6 Russia CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.4.7 Nordic Countries CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.4.8 Benelux CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia CNS Specific Antisense Oligonucleotides Revenue, 2017-2028
        6.5.2 China CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.5.3 Japan CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.5.4 South Korea CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.5.5 Southeast Asia CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.5.6 India CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America CNS Specific Antisense Oligonucleotides Revenue, 2017-2028
        6.6.2 Brazil CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.6.3 Argentina CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue, 2017-2028
        6.7.2 Turkey CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.7.3 Israel CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.7.4 Saudi Arabia CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
        6.7.5 UAE CNS Specific Antisense Oligonucleotides Market Size, 2017-2028
7 Players Profiles
    7.1 Akcea Therapeutics, Inc.
        7.1.1 Akcea Therapeutics, Inc. Corporate Summary
        7.1.2 Akcea Therapeutics, Inc. Business Overview
        7.1.3 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.1.4 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.1.5 Akcea Therapeutics, Inc. Key News
    7.2 Ionis Pharmaceuticals Inc.
        7.2.1 Ionis Pharmaceuticals Inc. Corporate Summary
        7.2.2 Ionis Pharmaceuticals Inc. Business Overview
        7.2.3 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.2.4 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.2.5 Ionis Pharmaceuticals Inc. Key News
    7.3 Biogen Inc.
        7.3.1 Biogen Inc. Corporate Summary
        7.3.2 Biogen Inc. Business Overview
        7.3.3 Biogen Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.3.4 Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.3.5 Biogen Inc. Key News
    7.4 Sarepta Therapeutics
        7.4.1 Sarepta Therapeutics Corporate Summary
        7.4.2 Sarepta Therapeutics Business Overview
        7.4.3 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.4.4 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.4.5 Sarepta Therapeutics Key News
    7.5 Wave Life Sciences Ltd.
        7.5.1 Wave Life Sciences Ltd. Corporate Summary
        7.5.2 Wave Life Sciences Ltd. Business Overview
        7.5.3 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.5.4 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.5.5 Wave Life Sciences Ltd. Key News
    7.6 Dynacure
        7.6.1 Dynacure Corporate Summary
        7.6.2 Dynacure Business Overview
        7.6.3 Dynacure CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.6.4 Dynacure CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.6.5 Dynacure Key News
    7.7 ProQR Therapeutics N.V.
        7.7.1 ProQR Therapeutics N.V. Corporate Summary
        7.7.2 ProQR Therapeutics N.V. Business Overview
        7.7.3 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.7.4 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.7.5 ProQR Therapeutics N.V. Key News
    7.8 Stroke Therapeutic Inc.
        7.8.1 Stroke Therapeutic Inc. Corporate Summary
        7.8.2 Stroke Therapeutic Inc. Business Overview
        7.8.3 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Major Product Offerings
        7.8.4 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue in Global Market (2017-2022)
        7.8.5 Stroke Therapeutic Inc. Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CNS Specific Antisense Oligonucleotides Market Opportunities & Trends in Global Market
    Table 2. CNS Specific Antisense Oligonucleotides Market Drivers in Global Market
    Table 3. CNS Specific Antisense Oligonucleotides Market Restraints in Global Market
    Table 4. Key Players of CNS Specific Antisense Oligonucleotides in Global Market
    Table 5. Top CNS Specific Antisense Oligonucleotides Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global CNS Specific Antisense Oligonucleotides Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global CNS Specific Antisense Oligonucleotides Revenue Share by Companies, 2017-2022
    Table 8. Global Companies CNS Specific Antisense Oligonucleotides Product Type
    Table 9. List of Global Tier 1 CNS Specific Antisense Oligonucleotides Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CNS Specific Antisense Oligonucleotides Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - CNS Specific Antisense Oligonucleotides Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2023-2028
    Table 30. Akcea Therapeutics, Inc. Corporate Summary
    Table 31. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Product Offerings
    Table 32. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 33. Ionis Pharmaceuticals Inc. Corporate Summary
    Table 34. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Product Offerings
    Table 35. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 36. Biogen Inc. Corporate Summary
    Table 37. Biogen Inc. CNS Specific Antisense Oligonucleotides Product Offerings
    Table 38. Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 39. Sarepta Therapeutics Corporate Summary
    Table 40. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Product Offerings
    Table 41. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 42. Wave Life Sciences Ltd. Corporate Summary
    Table 43. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Product Offerings
    Table 44. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 45. Dynacure Corporate Summary
    Table 46. Dynacure CNS Specific Antisense Oligonucleotides Product Offerings
    Table 47. Dynacure CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 48. ProQR Therapeutics N.V. Corporate Summary
    Table 49. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Product Offerings
    Table 50. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
    Table 51. Stroke Therapeutic Inc. Corporate Summary
    Table 52. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Product Offerings
    Table 53. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. CNS Specific Antisense Oligonucleotides Segment by Type in 2021
    Figure 2. CNS Specific Antisense Oligonucleotides Segment by Application in 2021
    Figure 3. Global CNS Specific Antisense Oligonucleotides Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global CNS Specific Antisense Oligonucleotides Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global CNS Specific Antisense Oligonucleotides Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CNS Specific Antisense Oligonucleotides Revenue in 2021
    Figure 8. By Type - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 9. By Application - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 10. By Region - Global CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 11. By Country - North America CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 12. US CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 16. Germany CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 17. France CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 24. China CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 28. India CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 30. Brazil CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa CNS Specific Antisense Oligonucleotides Revenue Market Share, 2017-2028
    Figure 33. Turkey CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE CNS Specific Antisense Oligonucleotides Revenue, (US$, Mn), 2017-2028
    Figure 37. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Biogen Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Dynacure CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
CNS Specific Antisense Oligonucleotides Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CNS Specific Antisense Oligonucleotides Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CNS Specific Antisense Oligonucleotides Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports